BALYASNY ASSET MANAGEMENT L.P. - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 114 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$5,000
-95.0%
32,480
-46.4%
0.00%
Q2 2021$101,000
+46.4%
60,602
+48.2%
0.00%
Q1 2021$69,000
-55.2%
40,881
-9.6%
0.00%
-100.0%
Q1 2018$154,00045,2000.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Cypress Capital Management LLC (WY) 234,225$132,0000.18%
Noven Financial Group, Inc. 123,772$70,0000.04%
Harvest Investment Services, LLC 109,443$60,0000.04%
GSA CAPITAL PARTNERS LLP 559,489$314,0000.03%
COURIER CAPITAL LLC 354,973$199,0000.03%
Valeo Financial Advisors, LLC 330,000$185,0000.02%
Transform Wealth, LLC 205,481$115,0000.02%
WEDBUSH SECURITIES INC 326,793$184,0000.02%
STEEL GROVE CAPITAL ADVISORS, LLC 55,500$31,0000.02%
MONTAG A & ASSOCIATES INC 230,000$129,0000.01%
View complete list of AMPIO PHARMACEUTICALS INC shareholders